MLH1 and colorectal cancer: However, the MSI phenotype is also observed due to somatic mutations in MMR genes or based on hypermethylation of the MLH1 promoter in approximately 15% of sporadic colorectal cancers, therefore it is not a specific marker for LS [12–17].